Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00417) | |||||
---|---|---|---|---|---|
Name |
Methyldopa
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
methyldopa; 555-30-6; Alphamethyldopa; Aldomet; Dopamet; Alpha medopa; Methyl dopa; l-alpha-Methyldopa; alpha-Methyl dopa; Baypresol; Hyperpax; Presolisin; Sedometil; Medomet; L-(-)-alpha-Methyldopa; Methyldopa anhydrous; 3-(3,4-DIHYDROXYPHENYL)-2-METHYL-L-ALANINE; Methyl-L-dopa; L-Methyl Dopa; Methyldopum; Metildopa; (S)-(-)-alpha-Methyldopa; L-(alpha-Md); 3-Hydroxy-alpha-methyl-L-tyrosine; L-alpha-Methyl DOPA; Sembrina; Dopegyt; alpha-Methyl-L-dopa; Dopamethyperpax; Aldometil; Grospisk; Medopren; Methoplain; Presinol; Becanta; Dopatec; Hypolag; Medopa; Medopal; alpha-Methyldopa (VAN); alpha-Methyldopa; Aldoril; alpha-Methyldihydroxyphenylalanine; alpha-Methyl-L-3,4-dihydroxyphenylalanine; L-alpha-Methyl-3,4-dihydroxyphenylalanine; L-Methyldopa; l-3-(3,4-Dihydroxyphenyl)-2-methylalanine; (S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid; Aldoril D30; Aldoril D50; Methyldopa (L,-); Bayer 1440 L; levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine; C10H13NO4; L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine; alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine; L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine; L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine; UNII-M4R0H12F6M; Methyldopa (INN); Methyldopa [INN]; L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid; (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid; MK-351;Methyldopa; CHEBI:61058; 41372-08-1; alpha-Methyldopa sesquihydrate; Aldomet (TN); Dopegit; MLS000028644; M4R0H12F6M; MK-351; Apo-Methyldopa; Nu-Medopa; Methyldopa hydrate; Novomedopa; SMR000059170; Methyldopum [INN-Latin]; Metildopa [INN-Spanish]; 3-(3,4-Dihydroxyphenyl)-2-methyl-L-alanine sesquihydrate; Methyldopa (anhydrous); 3-Hydroxy-.alpha.-methyl-L-tyrosine; L-Tyrosine, 3-hydroxy-alpha-methyl-; CCRIS 4671; HSDB 218; SR-01000597712; EINECS 209-089-2; Methyldopa (Levorotatory); NSC 169916; Medoba; l-a-methyldopa; a-methyl dopa; NSC169916; a-methyl-l-dopa; 3,4-Dihydroxy-2-methylphenylalanine #; NSC-169916; Anhydrous methyldopa; CAS-555-30-6; Prestwick_732; (-)-a-methyldopa; a-methyldopa (van); Methyldopa (Aldomet); 88620-56-8; Alanine, 3-(3,4-dihydroxyphenyl)-2-methyl-, L-(-)-; Methyldopa 250 Tab; (-)-alpha-methyldopa; L-(-)--Methyldopa; L(-)-a-methylalanine; Spectrum_000937; Tocris-0584; MK-351; Methyldopa; Nu-Medopa Tab 125mg; Nu-Medopa Tab 250mg; Nu-Medopa Tab 500mg; L-(-)-?-Methyldopa; (-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine Sesqui-Hydrate; Novo-Medopa Tab 125mg; Novo-Medopa Tab 250mg; Novo-Medopa Tab 500mg; Prestwick0_000326; Prestwick1_000326; Prestwick2_000326; Prestwick3_000326; Spectrum2_001068; Spectrum3_000501; Spectrum4_000054; Spectrum5_001295; (s)-(-)-a-methyldopa; L(-)-alpha-methylalanine; DSSTox_CID_3295; CHEMBL459; Epitope ID:146097; L-(-)- alpha-Methyldopa; Apo Methyldopa Tab 125mg; Apo Methyldopa Tab 250mg; Apo Methyldopa Tab 500mg; DSSTox_RID_76962; DSSTox_GSID_23295; L-(a-MD); Lopac0_000853; SCHEMBL34003; BSPBio_000331; BSPBio_002021; KBioGR_000547; KBioSS_001417; cid_38853; MLS006011978; BAYER-1440L; BIDD:GT0620; DivK1c_000142; Methyldopa 125 Tab 125mg; Methyldopa 500 Tab 500mg; SPECTRUM1500403; SPBio_001056; SPBio_002252; alpha-Methyl-dopa sesquihydrate; BPBio1_000365; GTPL5217; DTXSID5023295; BDBM48449; HMS500H04; KBio1_000142; KBio2_001417; KBio2_003985; KBio2_006553; KBio3_001521; ZINC20255; 5-amino-2-fluorophenylboronicacid; NINDS_000142; HMS1569A13; HMS1920N09; HMS2090B11; HMS2091F04; HMS2096A13; HMS2235N11; HMS3262L07; HMS3372J14; HMS3411G18; HMS3675G18; HMS3713A13; HMS3887I15; Pharmakon1600-01500403; L-(-)-a-methyl-a-methyl-Aldomin; HY-B0225; Tox21_202610; Tox21_500853; ANW-43632; CCG-40120; CM0081; DL-443; MFCD00004186; NSC760080; Tyrosine, 3-hydroxy-.alpha.-methyl-; a-Methyl-L-3,4-dihydroxyphenylalanine; AKOS015960582; AC-8431; DB00968; J9.247I; KS-1424; LP00853; MCULE-8885874119; NSC-760080; SDCCGSBI-0050829.P002; IDI1_000142; NCGC00024667-01; NCGC00024667-02; NCGC00024667-03; NCGC00024667-05; NCGC00024667-06; NCGC00024667-07; NCGC00024667-08; NCGC00024667-09; NCGC00024667-10; NCGC00024667-11; NCGC00024667-13; NCGC00024667-21; NCGC00260158-01; NCGC00261538-01; AC-11671; AK114179; AS-13052; L-(-)-alpha-methyl-alpha-methyl-Aldomin; L-a-Methyl-(3, 4-dihydroxyphenyl)alanine; EU-0100853; 3-(3,4-Dihydroxyphenyl)-?-methyl-L-alanine; L-alpha-Methyl-(3, 4-dihydroxyphenyl)alanine; C07194; D08205; AB00052043_09; AB01275508-01; AB01275508_02; 3-(3,4-Dihydroxyphenyl)-alpha-methyl-L-a lanine; Q412621; L-(-)-3-(3,4-dihydroxyphenyl)-2-methyl-Alanine; Q-201392; SR-01000597712-1; SR-01000597712-3; W-105555; 3,4-dihydroxy-2-methylphenylalanine (ACD/Name 4.0); Z1565440340; Methyldopa, European Pharmacopoeia (EP) Reference Standard; UNII-33TD13T99R component CJCSPKMFHVPWAR-JTQLQIEISA-N; (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid; Methyldopa, United States Pharmacopeia (USP) Reference Standard; L-(-)-AfAE'A centa' notA inverted exclamation markAfasA'A; AfAE'Adaggeratrade mark?-Methyldopa
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Essential hypertension | ICD-11: BA00 | [1] | ||
PubChem CID | |||||
Formula |
C10H13NO4
|
||||
Canonical SMILES |
C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N
|
||||
InChI |
1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1
|
||||
InChIKey |
CJCSPKMFHVPWAR-JTQLQIEISA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=38853"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 211.21 | Topological Polar Surface Area | 104 | |
XlogP | -1.9 | Complexity | 246 | ||
Heavy Atom Count | 15 | Rotatable Bond Count | 3 | ||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Methyldopa 250 mg tablet | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health; Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Citric acid; Magnesium stearate; Calcium sulfate; Edetate disodium; Talc; Titanium dioxide; Silicon dioxide; Ethylcellulose (10 mpa.s); Hydroxypropyl cellulose; Hypromelloses; Methylcellulose (15 cps); Polyethylene glycol; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Povidone; Cellulose, microcrystalline; Hypromelloses; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Accord Healthcare | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Cellulose, microcrystalline; Hypromelloses; Povidones; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Calcium sulfate; Citric acid monohydrate; Edetate disodium; Talc; Titanium dioxide; Silicon dioxide; Ethylcelluloses; Hydroxypropyl cellulose; Hypromelloses; Methylcellulose (400 cps); Polyethylene glycol; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Calcium sulfate; Citric acid monohydrate; Edetate disodium; Talc; Titanium dioxide; Silicon dioxide; Ethylcelluloses; Hydroxypropyl cellulose (type h); Hypromellose 2910 (3 mpa.s); Methylcellulose (400 mpa.s); Polyethylene glycols; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Calcium sulfate; Citric acid monohydrate; Edetate disodium; Talc; Titanium dioxide; Silicon dioxide; Ethylcelluloses; Hydroxypropyl cellulose (type h); Hypromelloses; Methylcellulose (400 mpa.s); Polyethylene glycols; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Calcium sulfate; Citric acid monohydrate; Edetate disodium; Talc; Titanium dioxide; Silicon dioxide; Ethylcelluloses; Hydroxypropyl cellulose; Hypromelloses; Methylcellulose (400 mpa.s); Polyethylene glycols; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Methyldopa 500 mg tablet | Click to Show/Hide the Full List of Formulation(s): 6 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Citric acid; Magnesium stearate; Edetate disodium; Titanium dioxide; Polysorbate 80; Silicon dioxide; Ethylcellulose (10 mpa.s); Hypromelloses; Methylcellulose (15 cps); Polyethylene glycol; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [5] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Povidone; Cellulose, microcrystalline; Hypromelloses; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Accord Healthcare; Avera McKennan Hospital | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Hypromellose, unspecified; Microcrystalline cellulose; Povidone, unspecified; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Citric acid monohydrate; Edetate disodium; Titanium dioxide; Polysorbate 80; Silicon dioxide; Ethylcelluloses; Hypromelloses; Methylcellulose (400 cps); Polyethylene glycol; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Calcium sulfate; Citric acid monohydrate; Edetate disodium; Talc; Titanium dioxide; Silicon dioxide; Ethylcelluloses; Hydroxypropyl cellulose (type h); Hypromellose 2910 (3 mpa.s); Methylcellulose (400 mpa.s); Polyethylene glycols; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.